Ledipasvir/Sofosbuvir Fixed-Dose Combination With Ribavirin or GS-9669 in Subjects With Chronic Genotype 1 HCV Infection

NCT01984294 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic HCV Infection

Interventions

DRUG: LDV/SOF
DRUG: RBV
DRUG: GS-9669

Sponsor

Gilead Sciences